GE HealthCare Technologies Inc. GEHC
Price alert —
Sign in to get a one-time email the moment GEHC crosses your price. Free accounts included.
Sign in / create a free accountPrice chart
Loading…
Latest bar · GEHC
Momentum reads · latest daily barGreen means room to run, red means stretched — the reads re-read live as you switch the chart's timeframe. MFI(14) is a volume-weighted money-flow read: above 80 = overbought, below 20 = oversold.
Financial overlay · last 12 quarters
The story behind the price: three years of quarterly results laid over the chart, so you can see whether the stock has been following the business — or running ahead of it.
| Quarter | Revenue | Net income | Op income | FCF | Net margin | Op margin |
|---|---|---|---|---|---|---|
| 2026-03-31 | $5.1B | $0.4B | $0.5B | $0.1B | 7.6% | 10.0% |
| 2025-12-31 | $5.7B | $0.6B | $0.8B | $0.9B | 10.3% | 14.5% |
| 2025-09-30 | $5.1B | $0.4B | $0.7B | $0.5B | 8.7% | 12.7% |
| 2025-06-30 | $5.0B | $0.5B | $0.7B | $0.0B | 9.7% | 13.1% |
| 2025-03-31 | $4.8B | $0.6B | $0.6B | $0.1B | 11.8% | 13.1% |
| 2024-12-31 | $nanB | $nanB | $nanB | $nanB | nan% | nan% |
Tip: toggle P/E, FCF, ROE, Gross margin and more on the chart above — every overlay is free.
Compare GEHC vs peers
Line GEHC up against up to 4 peers (5 tickers total) across ~30 metrics and get one weighted 0-100 verdict — best in green, worst in red. Peers also overlay on the chart above as rebased % lines, or flip the chart to the 2×2 grid for side-by-side mini charts.
Add tickers to compare with GEHC
~30 metrics across Snapshot, OdysseyHQ zone, Valuation, Growth, Quality, Technicals, Sentiment, and Risk — with a weighted score and a one-line read on each.
Earnings replay · last 14 reports
How this stock actually behaves on report day: each past earnings print with the beat-or-miss and the next-day move — a track record for handicapping the next one.
| Date | EPS actual | EPS est | Surprise | Next-day |
|---|---|---|---|---|
| 2026-04-29 | 0.99 | 1.05 | -5.7% | +2.3% |
| 2026-02-04 | 1.44 | 1.40 | +3.0% | -0.4% |
| 2025-10-29 | 1.07 | 1.05 | +2.2% | -3.1% |
| 2025-07-30 | 1.06 | 0.92 | +15.5% | -0.5% |
| 2025-04-30 | 1.01 | 0.91 | +10.6% | -3.8% |
| 2025-02-13 | 1.45 | 1.26 | +14.8% | -1.4% |
| 2024-10-30 | 1.14 | 1.05 | +8.3% | +0.2% |
| 2024-07-31 | 1.00 | 0.98 | +2.4% | -1.4% |
| 2024-04-30 | 0.90 | 0.91 | -0.7% | +2.6% |
| 2024-02-06 | 1.18 | 1.07 | +9.8% | -0.2% |
| 2023-10-31 | 0.99 | 0.90 | +10.4% | +2.6% |
| 2023-07-25 | 0.92 | 0.87 | +5.8% | -3.5% |
| 2023-04-25 | 0.85 | 0.79 | +7.3% | -0.3% |
| 2023-01-30 | 1.21 | 1.06 | +14.2% | -2.8% |
Earnings markers are overlaid on the daily price chart above. Click a ▲ marker for that day's move.
Peer comparison · Healthcare
Context check: the same key numbers for the closest Healthcare names side by side, so you can tell whether this stock is the standout or just moving with its group.
| Ticker ⇅ | Mkt cap ⇅ | P/E ⇅ | Fwd P/E ⇅ | P/S ⇅ | EV/EBITDA ⇅ | P/B ⇅ | Gross M ⇅ | Rev gr ⇅ | EPS gr ⇅ | FCF yld ⇅ |
|---|---|---|---|---|---|---|---|---|---|---|
| GEHC ★ | $29B | 15.1 | 11.7 | 1.4 | 10.6 | 2.7 | 39.1% | 7.4% | -30.9% | 5.19% |
| LLY | $1,023B | 40.7 | 25.5 | 14.2 | 30.1 | 32.8 | 82.8% | 55.5% | 169.9% | 0.90% |
| UNH | $383B | 31.7 | 18.8 | 0.9 | 17.7 | 3.9 | 19.5% | 0.4% | 61.5% | 5.95% |
| JNJ | $599B | 28.8 | 19.4 | 6.1 | 18.4 | 7.4 | 68.1% | 6.6% | -1.0% | — |
| MRK | $307B | 35.1 | 12.9 | 4.7 | 11.9 | 6.7 | 76.7% | 4.9% | — | 4.57% |
| ABBV | $448B | 124.2 | 15.6 | 7.1 | 17.1 | -67.3 | 72.0% | 12.4% | -46.2% | 4.65% |
| PFE | $141B | 18.9 | 8.7 | 2.2 | 7.6 | 1.6 | 74.8% | 5.4% | -10.1% | 8.77% |
| TMO | $196B | 28.9 | 19.3 | 4.3 | 20.9 | 3.8 | 40.9% | 6.2% | 11.3% | 2.82% |
Auto-seeded from sector. Click any ticker to switch.
Ownership
Who holds the stock and what they've been doing lately — big funds on the left, executives' own buys and sells on the right. Insider buying is the rarer, louder signal.
Top institutional holders
Top-10 concentration: 47.09%
| Holder | Shares | % out |
|---|---|---|
| Blackrock Inc. | 35,984,327 | 7.91% |
| Dodge & Cox Inc. | 31,312,064 | 6.88% |
| Vanguard Capital Management LLC | 28,864,188 | 6.35% |
| Capital Research Global Investors | 21,108,753 | 4.64% |
| State Street Corporation | 20,538,476 | 4.52% |
| Vanguard Portfolio Management LLC | 19,183,157 | 4.22% |
| Invesco Ltd. | 17,303,439 | 3.80% |
| Harris Associates L.P. | 15,594,988 | 3.43% |
| Geode Capital Management, LLC | 12,399,635 | 2.73% |
| Barrow, Hanley Mewhinney & Strauss, | 11,884,588 | 2.61% |
Insider activity · 90d
14 buys / 0 sells · ratio 14.0 · Finnhub
- Lobo Kevin BUY 14,363 @ $64.18
- Rackliffe Philip BUY 43,187
- Bankes Jeannette F 38,357 @ $62.67
- Hochman Rodney F BUY 1,618 @ $62.03
- Yang Watkin Phoebe L. BUY 13,702 @ $63.01
- Yang Watkin Phoebe L. BUY 12,702
- Madden Anne T BUY 19,479
- Madden Anne T BUY 17,197
- Lobo Kevin BUY 4,363
- Hochman Rodney F BUY 19,886
Analyst estimates
FinnhubWhat Wall Street expects next: the consensus forecasts for the coming quarters. The market usually reacts to results versus these numbers, not the raw results themselves.
SEC filings
The company's own paperwork, straight from the regulator — annual and quarterly reports, big announcements and insider trades. The primary source behind every headline.
| Form | Filed | Description | Action |
|---|---|---|---|
| 4 | 2026-05-26 | FORM 4 | view · |
| 4 | 2026-05-19 | FORM 4 | view · |
| 4 | 2026-05-19 | FORM 4 | view · |
| 4 | 2026-05-13 | FORM 4 | view · |
| 4 | 2026-05-11 | FORM 4 | view · |
| 4 | 2026-05-11 | FORM 4 | view · |
| 4 | 2026-05-11 | FORM 4 | view · |
| 4 | 2026-05-11 | FORM 4 | view · |
| 4 | 2026-05-11 | FORM 4 | view · |
| 4 | 2026-05-11 | FORM 4 | view · |
| 4 | 2026-05-11 | FORM 4 | view · |
| 8-K | 2026-05-11 | 8-K | view · |
| 4 | 2026-05-07 | FORM 4 | view · |
| 4 | 2026-05-07 | FORM 4 | view · |
| 4 | 2026-05-01 | FORM 4 | view · |
| 4 | 2026-04-30 | FORM 4 | view · |
| 4 | 2026-04-30 | FORM 4 | view · |
| 10-Q | 2026-04-29 | 10-Q | view · |
| 8-K | 2026-04-29 | 8-K | view · |
| DEF 14A | 2026-03-19 | DEF 14A | view · |
| 4 | 2026-03-17 | FORM 4 | view · |
| 8-K | 2026-03-17 | 8-K | view · |
| 4 | 2026-03-04 | FORM 4 | view · |
| 4 | 2026-03-04 | FORM 4 | view · |
| 4 | 2026-03-04 | FORM 4 | view · |
| 4 | 2026-03-04 | FORM 4 | view · |
| 4 | 2026-03-04 | FORM 4 | view · |
| 4 | 2026-03-04 | FORM 4 | view · |
| 4 | 2026-03-04 | FORM 4 | view · |
| 4 | 2026-03-04 | FORM 4 | view · |
| 4 | 2026-03-04 | FORM 4 | view · |
| 4 | 2026-03-04 | FORM 4 | view · |
| 8-K | 2026-02-27 | 8-K | view · |
| 4 | 2026-02-17 | FORM 4 | view · |
| 4 | 2026-02-17 | FORM 4 | view · |
| 4 | 2026-02-17 | FORM 4 | view · |
| 4 | 2026-02-17 | FORM 4 | view · |
| 4 | 2026-02-17 | FORM 4 | view · |
| 4 | 2026-02-17 | FORM 4 | view · |
| 4 | 2026-02-17 | FORM 4 | view · |
| 4 | 2026-02-17 | FORM 4 | view · |
| 10-K | 2026-02-04 | 10-K | view · |
| 8-K | 2026-02-04 | 8-K | view · |
| 4 | 2026-02-03 | FORM 4 | view · |
| 4 | 2026-02-03 | FORM 4 | view · |
| 4 | 2026-02-03 | FORM 4 | view · |
| 4 | 2026-02-03 | FORM 4 | view · |
| 4 | 2026-02-03 | FORM 4 | view · |
| 4 | 2026-02-03 | FORM 4 | view · |
| 4 | 2026-02-03 | FORM 4 | view · |
| 4 | 2026-02-03 | FORM 4 | view · |
| 8-K | 2025-12-15 | 8-K | view · |
| 8-K | 2025-12-02 | 8-K | view · |
| 10-Q | 2025-10-29 | 10-Q | view · |
| 8-K | 2025-10-29 | 8-K | view · |
| 4 | 2025-09-12 | FORM 4 | view · |
| 4 | 2025-09-03 | FORM 4 | view · |
| 4 | 2025-09-03 | FORM 4 | view · |
| 4 | 2025-09-03 | FORM 4 | view · |
| 4 | 2025-09-03 | FORM 4 | view · |
About GEHC
GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Advanced Visualization Solutions (AVS), Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). The Imaging segment offers molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, X-ray systems, and women's health products. The AVS segment provides ultrasound, image guided therapies, and interventional solutions for screening, diagnosis, treatment, and monitoring of certain diseases in clinical areas, such as women's health, cardiovascular, and comprehensive care ultrasound as well as surgical visualization and guidance products. The PCS segment provides medical devices, consumables, services, and digital solutions. Its portfolio includes patient monitoring, diagnostic cardiology, consumables and services, digital solutions, maternal infant care, and anesthesia products. The PDx segment supplies diagnostic agents, including CT, angiogr…
Options picks · GEHC
ITM + OTM ideas from the latest scanLoading…
Congress trades · GEHC
STOCK Act disclosuresLoading…
SEC filings & insiders · GEHC
EDGAR · liveLoading…
Holders · GEHC
Institutions & insider activityLoading…